Shuttle Pharmaceuticals Holdings, Inc. announced that it has entered into a securities purchase agreement with new investor, SRO, LLC to issue units for the gross proceeds of $2,250,000 on February 7, 2024. Each unit consists of one share of SHPH common stock and a warrant to purchase one share of SHPH common stock exercisable at a purchase price of $2.35 per share. The Units will be sold at a per Unit price equal to 90% of the VWAP of SHPH common stock for the five trading days immediately preceding closing.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5098 USD | -5.24% | +22.87% | +12.04% |
1st Jan change | Capi. | |
---|---|---|
+12.04% | 9.05M | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- SHPH Stock
- News Shuttle Pharmaceuticals Holdings, Inc.
- Shuttle Pharmaceuticals Holdings, Inc. announced that it expects to receive $2.25 million in funding